181 related articles for article (PubMed ID: 29966516)
1. Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia.
Shoukat A; Vilches T; Moghadas SM
BMC Med; 2018 Jul; 16(1):100. PubMed ID: 29966516
[TBL] [Abstract][Full Text] [Related]
2. The Potential Economic Value of a Zika Vaccine for a Woman of Childbearing Age.
Bartsch SM; Asti L; Stokes-Cawley OJ; Sim SY; Bottazzi ME; Hotez PJ; Lee BY
Am J Prev Med; 2020 Mar; 58(3):370-377. PubMed ID: 31980305
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of Prophylactic Zika Virus Vaccine in the Americas.
Shoukat A; Vilches T; Moghadas SM
Emerg Infect Dis; 2019 Dec; 25(12):2191-2196. PubMed ID: 31742512
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
5. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
[TBL] [Abstract][Full Text] [Related]
6. Reducing Unintended Pregnancies as a Strategy to Avert Zika-Related Microcephaly Births in the United States: A Simulation Study.
Ahrens KA; Hutcheon JA; Gavin L; Moskosky S
Matern Child Health J; 2017 May; 21(5):982-987. PubMed ID: 28102503
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
[TBL] [Abstract][Full Text] [Related]
8. Dengue dynamics and vaccine cost-effectiveness in Brazil.
Durham DP; Ndeffo Mbah ML; Medlock J; Luz PM; Meyers LA; Paltiel AD; Galvani AP
Vaccine; 2013 Aug; 31(37):3957-61. PubMed ID: 23791696
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of dengue vaccination in ten endemic countries.
Zeng W; Halasa-Rappel YA; Baurin N; Coudeville L; Shepard DS
Vaccine; 2018 Jan; 36(3):413-420. PubMed ID: 29229427
[TBL] [Abstract][Full Text] [Related]
10. A Cost-Effectiveness Tool for Informing Policies on Zika Virus Control.
Alfaro-Murillo JA; Parpia AS; Fitzpatrick MC; Tamagnan JA; Medlock J; Ndeffo-Mbah ML; Fish D; Ávila-Agüero ML; Marín R; Ko AI; Galvani AP
PLoS Negl Trop Dis; 2016 May; 10(5):e0004743. PubMed ID: 27205899
[TBL] [Abstract][Full Text] [Related]
11. Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis.
Holubar M; Stavroulakis MC; Maldonado Y; Ioannidis JP; Contopoulos-Ioannidis D
PLoS One; 2017; 12(3):e0172414. PubMed ID: 28249046
[TBL] [Abstract][Full Text] [Related]
12. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.
Demarteau N; Van Kriekinge G; Simon P
Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
[TBL] [Abstract][Full Text] [Related]
14. The Potential Cost Effectiveness of Different Dengue Vaccination Programmes in Malaysia: A Value-Based Pricing Assessment Using Dynamic Transmission Mathematical Modelling.
Shafie AA; Yeo HY; Coudeville L; Steinberg L; Gill BS; Jahis R; Amar-Singh Hss
Pharmacoeconomics; 2017 May; 35(5):575-589. PubMed ID: 28205150
[TBL] [Abstract][Full Text] [Related]
15. Modeling Zika Vaccination Combined With Vector Interventions in DoD Populations.
Burgess C; Nelis L; Huang C
Mil Med; 2021 Jan; 186(Suppl 1):82-90. PubMed ID: 33499489
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
Pearson CAB; Bozzani F; Procter SR; Davies NG; Huda M; Jensen HT; Keogh-Brown M; Khalid M; Sweeney S; Torres-Rueda S; ; ; Eggo RM; Vassall A; Jit M
PLoS Med; 2021 Oct; 18(10):e1003815. PubMed ID: 34606520
[TBL] [Abstract][Full Text] [Related]
17. What Is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks?
Bartsch SM; Asti L; Cox SN; Durham DP; Randall S; Hotez PJ; Galvani AP; Lee BY
J Infect Dis; 2019 Aug; 220(6):920-931. PubMed ID: 30544164
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
20. Can Vaccination Save a Zika Virus Epidemic?
Valega-Mackenzie W; Ríos-Soto KR
Bull Math Biol; 2018 Mar; 80(3):598-625. PubMed ID: 29359251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
